MEDICAL MARIJUANA

Scythian CEO on the potential impact of cannabinoid drugs on traumatic brain injuries



August 29, 2017 — Jonathan Gilbert, CEO and Director, and David Schrader, COO of Scythian Biosciences Corp. (TSXV: SCYB) (“Scythian”) in an interview with …

source

Leave a Reply

Your email address will not be published. Required fields are marked *